On Monday, Shares of The Coca-Cola Co (NYSE:KO), lost -0.24% to $41.67.
The Coca-Cola Foundation awarded $26.2 million USD to 74 community organizations during the first half of 2015. These grants will benefit more than 90 million people across 76 countries, and are focused on The Coca-Cola Company’s core sustainability priorities - women, water and well-being.
“As a global company operating in more than 200 countries, Coca-Cola is part of a large and diverse community and we are proud to support the well-being of the communities where we live and work,” said Lisa M. Borders, Chair, The Coca-Cola Foundation and Vice President, Global Community Affairs. “By working with local organizations, we are assisting to find solutions to the global challenges we collectively face.”
The Coca-Cola Company, a beverage company, manufactures and distributes various nonalcoholic beverages worldwide. The company primarily offers sparkling beverages and still beverages. Its sparkling beverages comprise nonalcoholic ready-to-drink beverages with carbonation, such as carbonated energy drinks, and carbonated waters and flavored waters.
Shares of Sorrento Therapeutics Inc (NASDAQ:SRNE), declined -4.72% to $17.37, during its last trading session.
Sorrento Therapeutics, declared that it in addition to its wholly-owned partner TNK Therapeutics, Inc. have reached a binding term sheet to exclusively license the NanoVelcro Circulating Tumor Cell (CTC) profiling assay technology from CytoLumina Technologies Corp. and FetoLumina Technologies Corp., two privately-held sister biotechnology companies in Los Angeles, California. The exclusive licenses will cover the applications of the NanoVelcro CTC assay and its portfolio technologies for precision medicine diagnostics in conjunction with all cellular therapies and Sorrento antibody therapeutics.
The NanoVelcro Chip is a device capable of enriching, isolating, and identifying CTCs from peripheral blood of cancer patients. Coupled with downstream molecular assays, it enables the characterization of individually isolated CTCs, thus providing diagnostic information for the monitoring of real-time disease progression and tailoring individualized therapy solutions for cancer patients. The NanoVelcro Chip utilizes antibody-coated nanostructured substrates to capture CTCs with high efficiency. Once the CTCs are immobilized on the NanoVelcro Chips, laser capture microdissection technology allows for selective recovery of the CTCs with single-cell precision, virtually eliminating any trace of contamination from white blood cells that might complicate further downstream analysis. Finally, the isolated and purified CTCs are subjected to in-depth molecular characterization, counting mutational analysis, copy number variance, expression profiling, multi-color protein staining in addition to quantification of key phospho-proteins in signal transduction networks. These CTC-derived molecular signatures may assist doctors to implement personalized therapies targeting a patient’s unique cancer.
Sorrento Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, acquisition, development, and commercialization of proprietary drug therapeutics for addressing unmet medical needs in the United States, Europe, and internationally.
Finally, Telefonica S.A. (ADR) (NYSE:TEF), ended its last trade with 1.44% gain, and closed at $15.48.
Telefónica, presented its results corresponding to the first semester of 2015 and reports a net profit of 3,693 million euros, double the amount reached in the same period of 2014 (+105.4%). Additionally, the Company has raised revenue growth guidance for the full year to >9.5 % (vs. >7% formerly).
Telefónica consolidates its new growth cycle quarter after quarter. Up until June, and in stated terms, merged revenue grew +12.5% to 23,419 million euros, OIBDA raised +7.2% to 7,320 million euros, and earnings per share (0.75 euros per share) doubled contrast to the same period of 2014. At the end of June, Telefónica Group’s customer base raised +13% yoy to 329,4 million accesses.
Telefónica, S.A. provides fixed and mobile communication services primarily in Europe and Latin America. The company offers mobile voice, value added, mobile data and Internet, wholesale, corporate, roaming, fixed wireless, and trunking and paging services. DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
